Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Steven Brimijoin"'
Publikováno v:
Neurobiology of Disease, Vol 24, Iss 2, Pp 326-333 (2006)
Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor
Autor:
Tomas Hökfelt, Jan Hannibal, Steven Brimijoin, Hans Holgert, Kristina Holmberg, Boyd K. Hartman, Jan Fahrenkrug
Publikováno v:
NeuroReport. 8:297-301
Using indirect immunohistochemistry and immunological sympathectomy pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity (LI) was studied in the adult rat adrenal gland. All PACAP-positive fibres contained choline acetyltr
Autor:
Hans Holgert, Costatino Cozzari, Steven Brimijoin, Tomas Hökfelt, Åke Dagerlind, Boyd K. Hartman, Hugo Lagercrantz
Publikováno v:
Developmental Brain Research. 97:88-95
Administration of monoclonal antibodies against acetylcholinesterase (AChE-mabs) to adult rats leads to a selective degeneration of the acetylcholine esterase- (AChE), choline acetyltransferase- (ChAT) and enkephalin- (ENK) positive preganglionic fib
Publikováno v:
Alzheimer's & Dementia. 2
Autor:
Steven Brimijoin, Piers C. Emson, Costatino Cozzari, Hans Holgert, Boyd K. Hartman, Tomas Hökfelt, Katarina Åman, Menek Goldstein
Publikováno v:
Neuroreport. 6(18)
Using a monoclonal antibody against rat brain choline acetyltransferase (ChAT) the cholinergic innervation of the adult rat adrenal gland was visualized. Almost all ChAT-positive fibres contained nitric oxide synthase (NOS), whereas enkephalin (ENK)
Autor:
Pamela I. Hammond, W. Steven Brimijoin
Publikováno v:
Mayo Clinic proceedings. 60(1)
Energy metabolism was examined in rat sciatic nerve before and after induction of neuropathy by treatment with acrylamide monomer. The in vivo activities of two glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase and nerve-specific enolase,
The development of a sensitive and specific enzymatic assay for dopamine-β-hydroxylase has enabled us to measure the activity of this enzyme in several tissues where it has previously been measured. The administration of reserpine leads to an increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cae1eb8a3fef784c081003dd4856953
https://europepmc.org/articles/PMC283066/
https://europepmc.org/articles/PMC283066/